Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...
Equities research analysts at Cantor Fitzgerald reduced their FY2025 earnings per share estimates for Metsera in a report issued on Thursday, March 27th. Cantor Fitzgerald analyst P. Agrawal now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback